Literature DB >> 8154349

Sickle cell nephropathy.

R J Falk1, J C Jennette.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8154349

Source DB:  PubMed          Journal:  Adv Nephrol Necker Hosp        ISSN： 0084-5957


× No keyword cloud information.
  9 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.

Authors:  Davoud Mohtat; Rosemary Thomas; Zangfang Du; Yaa Boakye; Thomas Moulton; Catherine Driscoll; Robert Woroniecki
Journal:  Pediatr Nephrol       Date:  2010-11-25       Impact factor: 3.714

Review 5.  Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Authors:  Teguh Haryo Sasongko; Srikanth Nagalla
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

6.  Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species.

Authors:  J Brett Heimlich; Joshua S Speed; Paul M O'Connor; Jennifer S Pollock; Tim M Townes; Steffen E Meiler; Abdullah Kutlar; David M Pollock
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

7.  Vascular complications of sickle cell disease.

Authors:  Ashar Usmani; Roberto F Machado
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 8.  Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Authors:  Teguh H Sasongko; Srikanth Nagalla; Samir K Ballas
Journal:  Cochrane Database Syst Rev       Date:  2015-06-04

Review 9.  Systemic lupus erythematosus in patients with sickle cell disease.

Authors:  Simone Appenzeller; Andre Fattori; Sarita T Saad; Lilian T L Costallat
Journal:  Clin Rheumatol       Date:  2007-11-14       Impact factor: 3.650
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.